All the news Showing 10 of 38 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources EASL recommendations on treatment of Hepatitis C 2020 EASL / 28 September 2020 GSK to develop Ionis hepatitis B drugs PM LIve / 30 August 2019 China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection Gilead press release / 20 November 2018 Janssen Announces Exclusive, Worldwide License Agreement With Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection Janssen press release / 05 October 2018 Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit Arrowhead / 07 September 2018 Curbing hepatitis B in the United States will save lives and money, according to a new study Stanford Medicine / 11 July 2018 'Virus-cracking' molecules advance fight against hepatitis B Science Daily / 07 February 2018 Are New Drugs for Hepatitis C Safe? A Report Raises Concerns New York Times / 25 January 2017 European Commission Grants Marketing Authorization for Gilead’s Vemlidy® (Tenofovir Alafenamide, TAF) for the Treatment of Chronic Hepatitis B Virus Infection Gilead press release / 11 January 2017 U.S. Food and Drug Administration Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection Gilead press release / 11 November 2016 ← First123...4Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive